Allied Biotech Corporation
1780.TWO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.69B
Close$
Share Statistics
| Market cap | $2.69 Billion |
|---|---|
| Enterprise Value | $2.28 Billion |
| Dividend Yield | $1.25 (5.07%) |
| Earnings per Share | $1.34 |
| Beta | 0.2 |
| Outstanding Shares | 97,646,376 |
Return
| Return on Equity | 15.13% |
|---|---|
| Return on Assets | 8.97% |
| Return on Invested Capital | 16.30% |
Valuation & Multiples
| P/E Ratio | 8.36 |
|---|---|
| PEG | -4.76 |
| Price to Sales | 1.45 |
| Price to Book Ratio | 1.64 |
| Enterprise Value to Revenue | 1.32 |
| Enterprise Value to EBIT | 8.98 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.5 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Allied Biotech Corporation
40 employees
CEO: Qing Hui Lin Allied Biotech Corporation operates as a global producer and supplier specializing in carotenoids. The company's diverse product portfolio features key carotenoids such as: Beta-Carotene, known for imparting vibrant yellow to reddish-ora...